CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities:
Net loss	$ (147,550)	$ (293,905)
Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization	12,147	9,043
Non-cash stock-based compensation	11,556	28,647
Provision for excess and obsolete inventory	8,807	12,490
Impairment of long-lived assets	1,669	0
Other items, net	(4,449)	(1,252)
Changes in operating assets and liabilities:
Inventory	16,819	(9,222)
Accounts receivable, prepaid expenses, and other assets	296,054	18,430
Accounts payable, accrued expenses, and other liabilities	(272,461)	(230,099)
Deferred revenue	(6,147)	140,275
Net cash used in operating activities	(83,555)	(325,593)
Investing Activities:
Capital expenditures	(6,878)	(19,801)
Internal-use software	(372)	(3,757)
Net cash used in investing activities	(7,250)	(23,558)
Financing Activities:
Net proceeds from sales of common stock	6,862	0
Net proceeds from the exercise of stock-based awards	(616)	543
Finance lease payments	(360)	(26,331)
Repayment of 2023 Convertible notes	0	(325,000)
Payments of costs related to issuance of 2027 Convertible notes	0	(3,591)
Net cash provided by (used in) financing activities	5,886	(354,379)
Effect of exchange rate on cash, cash equivalents, and restricted cash	(2,955)	(8,372)
Net decrease in cash, cash equivalents, and restricted cash	(87,874)	(711,902)
Cash, cash equivalents, and restricted cash at beginning of period	583,810	1,348,845
Cash, cash equivalents, and restricted cash at end of period	495,936	636,943
Supplemental disclosure of non-cash activities:
Capital expenditures included in accounts payable and accrued expenses	1,208	10,847
Internal-use software included in accounts payable and accrued expenses	250	0
Supplemental disclosure of cash flow information:
Cash interest payments, net of amounts capitalized	1,206	6,566
Cash paid for income taxes, net of refunds	$ (71)	$ 0